This track will explore the latest advancements in functional genomics and their applications in drug discovery and development. Researchers will present novel methodologies and findings that enhance our understanding of drug mechanisms and efficacy.

This session will focus on the development and application of therapeutic antibodies and cancer vaccines in oncology. Discussions will include recent breakthroughs and challenges in the clinical translation of these biotherapeutics.

This track will delve into the role of nanotechnology in the creation of innovative cancer therapies. Presentations will cover the design and efficacy of nanocarriers, including stealth nanoparticles and tumor-penetrating peptides.

This session will analyze the global market for anticancer drugs, focusing on their economic impact and cost-effectiveness. Researchers will discuss pricing strategies, accessibility, and the implications for healthcare systems.

This track will highlight cutting-edge drug delivery systems designed for cancer treatment. Emphasis will be placed on novel formulations and technologies that improve therapeutic outcomes and minimize side effects.

This session will investigate the complex interactions within the cancer microenvironment and their implications for tumor progression and therapy response. Researchers will present findings on how the microenvironment influences drug efficacy.